BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 9442787)

  • 1. Treatment of retinoblastoma vitreous base seeding.
    Madreperla SA; Hungerford JL; Doughty D; Plowman PN; Kingston JE; Singh AD
    Ophthalmology; 1998 Jan; 105(1):120-4. PubMed ID: 9442787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management and outcome of retinoblastoma with vitreous seeds.
    Manjandavida FP; Honavar SG; Reddy VA; Khanna R
    Ophthalmology; 2014 Feb; 121(2):517-24. PubMed ID: 24572675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Not All Seeds Are Created Equal: Seed Classification Is Predictive of Outcomes in Retinoblastoma.
    Berry JL; Bechtold M; Shah S; Zolfaghari E; Reid M; Jubran R; Kim JW
    Ophthalmology; 2017 Dec; 124(12):1817-1825. PubMed ID: 28655537
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors predictive of recurrence of retinal tumors, vitreous seeds, and subretinal seeds following chemoreduction for retinoblastoma.
    Shields CL; Honavar SG; Shields JA; Demirci H; Meadows AT; Naduvilath TJ
    Arch Ophthalmol; 2002 Apr; 120(4):460-4. PubMed ID: 11934319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemotherapy plus local treatment in the management of intraocular retinoblastoma.
    Murphree AL; Villablanca JG; Deegan WF; Sato JK; Malogolowkin M; Fisher A; Parker R; Reed E; Gomer CJ
    Arch Ophthalmol; 1996 Nov; 114(11):1348-56. PubMed ID: 8906025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined chemoreduction and adjuvant treatment for intraocular retinoblastoma.
    Shields CL; Shields JA; Needle M; de Potter P; Kheterpal S; Hamada A; Meadows AT
    Ophthalmology; 1997 Dec; 104(12):2101-11. PubMed ID: 9400771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemoreduction plus focal therapy for retinoblastoma: factors predictive of need for treatment with external beam radiotherapy or enucleation.
    Shields CL; Honavar SG; Meadows AT; Shields JA; Demirci H; Singh A; Friedman DL; Naduvilath TJ
    Am J Ophthalmol; 2002 May; 133(5):657-64. PubMed ID: 11992863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of induction chemotherapy in retinoblastoma, alone or combined with other adjuvant modalities.
    Ghose S; Nizamuddin SH; Sethi A; Mohanti BK; Kumar H; Arya LS; Thavaraj V
    J Pediatr Ophthalmol Strabismus; 2002; 39(3):143-50. PubMed ID: 12051279
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined chemotherapy and local treatment in the management of intraocular retinoblastoma.
    Brichard B; De Bruycker JJ; De Potter P; Neven B; Vermylen C; Cornu G
    Med Pediatr Oncol; 2002 Jun; 38(6):411-5. PubMed ID: 11984802
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vitreous relapse following primary chemotherapy for retinoblastoma: is adjuvant diode laser a risk factor?
    Gombos DS; Cauchi PA; Hungerford JL; Addison P; Coen PG; Kingston JE
    Br J Ophthalmol; 2006 Sep; 90(9):1168-72. PubMed ID: 16707528
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vitreous Seeds in Retinoblastoma: Clinicopathologic Classification and Correlation.
    Amram AL; Rico G; Kim JW; Chintagumpala M; Herzog CE; Gombos DS; Chévez-Barrios P
    Ophthalmology; 2017 Oct; 124(10):1540-1547. PubMed ID: 28528011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Causes of chemoreduction failure in retinoblastoma and analysis of associated factors leading to eventual treatment with external beam radiotherapy and enucleation.
    Gündüz K; Günalp I; Yalçindağ N; Unal E; Taçyildiz N; Erden E; Geyik PO
    Ophthalmology; 2004 Oct; 111(10):1917-24. PubMed ID: 15465557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intra-arterial Chemotherapy for Adult Onset Retinoblastoma in a 32-Year-Old Man.
    Magan T; Khoo CT; Jabbour PM; Fuller DG; Shields CL
    J Pediatr Ophthalmol Strabismus; 2016 Jul; 53():e43-6. PubMed ID: 27486894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemoreduction for unilateral retinoblastoma.
    Shields CL; Honavar SG; Meadows AT; Shields JA; Demirci H; Naduvilath TJ
    Arch Ophthalmol; 2002 Dec; 120(12):1653-8. PubMed ID: 12470138
    [TBL] [Abstract][Full Text] [Related]  

  • 15. INTRAVITREOUS CHEMOTHERAPY FOR ACTIVE VITREOUS SEEDING FROM RETINOBLASTOMA: Outcomes After 192 Consecutive Injections. The 2015 Howard Naquin Lecture.
    Shields CL; Douglass AM; Beggache M; Say EA; Shields JA
    Retina; 2016 Jun; 36(6):1184-90. PubMed ID: 26630319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Macular retinoblastoma managed with chemoreduction: analysis of tumor control with or without adjuvant thermotherapy in 68 tumors.
    Shields CL; Mashayekhi A; Cater J; Shelil A; Ness S; Meadows AT; Shields JA
    Arch Ophthalmol; 2005 Jun; 123(6):765-73. PubMed ID: 15955977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Eye-preservation treatment of retinoblastoma with vitreous seeding.
    Kaneko A; Suzuki S
    Jpn J Clin Oncol; 2003 Dec; 33(12):601-7. PubMed ID: 14769836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conservative treatments of intraocular retinoblastoma.
    Lumbroso-Le Rouic L; Aerts I; Lévy-Gabriel C; Dendale R; Sastre X; Esteve M; Asselain B; Bours D; Doz F; Desjardins L
    Ophthalmology; 2008 Aug; 115(8):1405-10, 1410.e1-2. PubMed ID: 18222001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical efficacy and prognostic factors of chemoreduction combined with topical treatment for advanced intraocular retinoblastoma.
    Liu Y; Zhang X; Liu F; Wang KL
    Asian Pac J Cancer Prev; 2014; 15(18):7805-9. PubMed ID: 25292067
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect on ocular survival of adding early intensive focal treatments to a two-drug chemotherapy regimen in patients with retinoblastoma.
    Wilson MW; Haik BG; Liu T; Merchant TE; Rodriguez-Galindo C
    Am J Ophthalmol; 2005 Sep; 140(3):397-406. PubMed ID: 16138999
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.